Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Further Reading

Mount Sinai receives $1 million grant to advance understanding of prostate cancer

Mount Sinai receives $1 million grant to advance understanding of prostate cancer

New model can help study the mechanisms of bone metastasis, tumor immune response

New model can help study the mechanisms of bone metastasis, tumor immune response

Movember and Alberta Cancer Foundation campaigns boost prostate cancer screening study

Movember and Alberta Cancer Foundation campaigns boost prostate cancer screening study

Transplant patients diagnosed with prostate cancer may not need to delay transplantation

Transplant patients diagnosed with prostate cancer may not need to delay transplantation

Study: As married couples age, coping with their own health demands may take a mental toll

Study: As married couples age, coping with their own health demands may take a mental toll

Roswell Park-led scientists identify new defense mechanism against prostate cancer

Roswell Park-led scientists identify new defense mechanism against prostate cancer

Study suggests two new approaches against bone metastases from prostate cancer

Study suggests two new approaches against bone metastases from prostate cancer

Radiologists at Mayo Clinic take procedural practice into the future

Radiologists at Mayo Clinic take procedural practice into the future

MRI-guided ultrasound ablation: safer better treatment for prostate cancer

MRI-guided ultrasound ablation: safer better treatment for prostate cancer

Simple urine test at home could revolutionize diagnosis of prostate cancer

Simple urine test at home could revolutionize diagnosis of prostate cancer

Home urine testing kit for prostate cancer could come soon

Home urine testing kit for prostate cancer could come soon

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Prostate cancer 'super responders' could live for two years or more on immunotherapy

New theranostic reagent could improve detection and treatment of prostate cancer

New theranostic reagent could improve detection and treatment of prostate cancer

Tandem radiation therapy effective in prostate cancer patients with no treatment options

Tandem radiation therapy effective in prostate cancer patients with no treatment options

Cancer patients have higher risk of cardiovascular death

Cancer patients have higher risk of cardiovascular death

Predicting opioid-related problems among cancer survivors

Predicting opioid-related problems among cancer survivors

Statin use may reduce risk of developing lethal prostate cancer

Statin use may reduce risk of developing lethal prostate cancer

Prostate cancer patients receiving care at MultiD clinic more likely to be advised about treatment choices

Prostate cancer patients receiving care at MultiD clinic more likely to be advised about treatment choices

Study explores the overall rate of new cancer cases in Canada from 1971 to 2015

Study explores the overall rate of new cancer cases in Canada from 1971 to 2015

Omega-3 supplement continues to protect heart health without increasing prostate cancer risk

Omega-3 supplement continues to protect heart health without increasing prostate cancer risk